Open Forum Infect Dis
. 2022 Oct 17;9(11):ofac544.
doi: 10.1093/ofid/ofac544. eCollection 2022 Nov.
Effect of Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster on Human Immunodeficiency Virus Reservoirs and Immune Markers
M Ali Rai 1 , Victoria Shi 1 , Brooke D Kennedy 1 , Jesse S Justement 1 , Kathleen Gittens 2 , Genevieve McCormack 1 , Jana Blazkova 1 , Susan Moir 1 , Tae-Wook Chun 1
Affiliations
- PMID: 36345429
- PMCID: PMC9619736
- DOI: 10.1093/ofid/ofac544
Abstract
We investigated effects of the severe acute respiratory syndrome coronavirus 2 (SARV-CoV-2) booster vaccination on human immunodeficiency virus (HIV) reservoir size, immune markers, and host immune responses in people with HIV receiving antiretroviral therapy. Our data suggest that the SARS-CoV-2 booster vaccine is not likely to replenish the persistent HIV reservoir nor provide an immunologic environment to facilitate active HIV expression/replication.
Keywords: HIV; HIV reservoirs; SARS-CoV-2; booster vaccine; immune markers and responses.